MassBio CEO Kendalle Burlin O’Connell
August 26, 2026 01:28 PM EDT
StartupsR&DChinaPharma
MassBio CEO calls 2025 ‘probably the most challenging year that I can remember’
Max Bayer
MassBio CEO calls 2025 ‘probably the most challenging year that I can remember’
MassBio report shows MA biopharma jobs fell 3.1%, NIH awards dropped 6%, while China's drug pipeline grew 36% in 2025, alarming CEO Kendalle Burlin O'Connell.
155 words~1 min read
